RxDoctor Payments Data

Rachael Nergart, PA

Family Medicine · Reading, PANPI 1811407638

Payments from drug & device makers

$1,678in general payments, 2019–2025

Across 90 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$317
  • Boehringer Ingelheim$297
  • Pfizer$167
  • Lilly USA, LLC$167
  • AbbVie$129
  • Otsuka America Pharmaceutical, Inc.$99
  • plus $502 from 11 others

What the payments were for

  • Food & beverage$1,678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,678 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$41,979
Medicare patients
200
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$27,203
JardianceEmpagliflozin18$23,658
JanuviaSitagliptin Phosphate13$16,988
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$14,076
MounjaroTirzepatide12$12,003
VascepaIcosapent Ethyl16$8,431
Repatha SureclickEvolocumab11$6,074
Albuterol Sulfate HfaAlbuterol Sulfate61$2,158
Atorvastatin Calcium150$1,700
Gabapentin73$1,129
SynthroidLevothyroxine Sodium13$1,080
Omeprazole67$996
Levothyroxine Sodium73$966
Losartan Potassium96$912
Rosuvastatin Calcium54$800

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$167$27,20339 claims
Boehringer IngelheimJardiance$297$23,65818 claims
MerckJanuvia$71$16,98813 claims
GSKTrelegy Ellipta$43$14,07616 claims
Lilly USA, LLCMounjaro$167$12,00312 claims
AbbVieSynthroid$129$1,08013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Reading

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →